Holen Sie sich die Stockscreener-App
7.69
2.29%
-0.18
Schlusskurs vom Vortag:
$7.87
Offen:
$7.9
24-Stunden-Volumen:
73,659
Relative Volume:
0.95
Marktkapitalisierung:
$740.80M
Einnahmen:
$106.66M
Nettoeinkommen (Verlust:
$15.16M
KGV:
82.25
EPS:
0.0935
Netto-Cashflow:
$6.37M
1W Leistung:
-3.63%
1M Leistung:
-7.79%
6M Leistung:
-4.71%
1J Leistung:
-21.37%
1-Tages-Spanne:
$7.67
$8.09
1-Wochen-Bereich:
$7.67
$8.50
52-Wochen-Spanne:
$6.11
$14.42
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Firmenname
Gyre Therapeutics Inc
Sektor
Branche
Telefon
(858) 567-7770
Adresse
12770 HIGH BLUFF DRIVE, SAN DIEGO
Vergleichen Sie GYRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
7.69 | 758.14M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-10 | Eingeleitet | Jefferies | Buy |
| 2025-08-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-11 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-04-29 | Fortgesetzt | Stephens | Overweight |
| 2021-02-10 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-21 | Eingeleitet | Raymond James | Outperform |
| 2019-01-04 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-12 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Eingeleitet | Chardan Capital Markets | Buy |
| 2017-06-06 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-06-30 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 5.9%Should You Sell? - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Is Gyre Therapeutics Stock Built to Withstand a Pullback? - Trefis
Regarding video postings related to our company group information on some social networking services (SNS). - 富途牛牛
Why Gyre Therapeutics Inc. stock remains on buy listsOptions Play & Verified Momentum Stock Alerts - BỘ NỘI VỤ
Published on: 2025-11-27 08:38:09 - BỘ NỘI VỤ
Is Gyre Therapeutics Inc a good long term investmentMarket Depth Overview & Free Unmatched Market Performance - earlytimes.in
Is Gyre Therapeutics Inc. stock a dividend growth opportunity2025 Short Interest & Real-Time Volume Triggers - newser.com
Is Gyre Therapeutics Inc. stock dividend yield sustainableJuly 2025 Closing Moves & Safe Entry Point Identification - newser.com
What drives Gyre Therapeutics Inc stock priceMarket Capitalization Trends & Free Triple Digit Wealth Increase - earlytimes.in
Will Gyre Therapeutics Inc. stock return to pre crisis levelsLong Setup & Low Risk High Win Rate Picks - newser.com
Should I hold or sell Gyre Therapeutics Inc. stock in 2025July 2025 Final Week & Verified Technical Signals - newser.com
Why Gyre Therapeutics Inc. stock remains on watchlistsMarket Activity Report & Weekly Chart Analysis and Guides - newser.com
What recovery options are there for Gyre Therapeutics Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Can Gyre Therapeutics Inc. stock sustain institutional interest2025 Biggest Moves & Smart Money Movement Tracker - newser.com
How Gyre Therapeutics Inc. stock performs in interest rate cyclesMarket Activity Recap & Daily Volume Surge Signals - newser.com
Is Gyre Therapeutics Inc. stock entering bullish territoryTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives $17.00 Average PT from Brokerages - Defense World
Will breakout in Gyre Therapeutics Inc. lead to full recoveryMarket Growth Report & Low Drawdown Momentum Trade Ideas - newser.com
How to forecast Gyre Therapeutics Inc. trends using time series2025 Volatility Report & Safe Entry Momentum Tips - newser.com
Analyzing Gyre Therapeutics Inc. with risk reward ratio charts2025 Trading Recap & Reliable Breakout Stock Forecasts - newser.com
Published on: 2025-11-16 00:46:46 - newser.com
Trend analysis for Gyre Therapeutics Inc. this weekQuarterly Trade Review & Risk Adjusted Buy/Sell Alerts - newser.com
What institutional flow reveals about Gyre Therapeutics Inc.Entry Point & Step-by-Step Swing Trade Plans - newser.com
Gyre Therapeutics (NASDAQ:GYRE) Stock Rating Upgraded by Wall Street Zen - Defense World
Is this a good reentry point in Gyre Therapeutics Inc.2025 Key Lessons & Long-Term Capital Growth Strategies - newser.com
Statistical indicators supporting Gyre Therapeutics Inc.’s strength2025 Market Overview & Smart Investment Allocation Insights - newser.com
Exploring High Growth Tech Stocks in the US Market - simplywall.st
Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):